BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24582012)

  • 1. Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy.
    Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Suzuki F; Fukuda S
    Br J Oral Maxillofac Surg; 2014 Apr; 52(4):323-8. PubMed ID: 24582012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of late neck recurrence in N0 maxillary sinus squamous cell carcinomas after superselective intra-arterial chemoradiotherapy without prophylactic neck irradiation.
    Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
    Eur Arch Otorhinolaryngol; 2014 Oct; 271(10):2767-70. PubMed ID: 24213278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined therapy after superselective arterial cisplatin infusion to treat maxillary squamous cell carcinoma.
    Shiga K; Yokoyama J; Hashimoto S; Saijo S; Tateda M; Ogawa T; Watanabe M; Kobayashi T
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):1003-9. PubMed ID: 17547996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose-finding phase.
    Homma A; Onimaru R; Matsuura K; Shinomiya H; Sakashita T; Shiga K; Tachibana H; Nakamura K; Mizusawa J; Kitahara H; Eba J; Fukuda H; Fujii M; Hayashi R
    Head Neck; 2018 Mar; 40(3):475-484. PubMed ID: 29130565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage surgery improves the treatment outcome of patients with residual/recurrent maxillary sinus cancer after superselective intra-arterial cisplatin infusion with concomitant radiation therapy.
    Tsushima N; Kano S; Suzuki T; Idogawa H; Yoshida D; Yasuda K; Otsuka M; Aoyama H; Homma A
    Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):899-905. PubMed ID: 33866400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoradiotherapy for maxillary sinus adenoid cystic carcinoma using superselective intra-arterial infusion via a superficial temporal artery.
    Adachi M; Mitsudo K; Yamamoto N; Hagiwara S; Shigetomi T; Fujimoto Y; Lai SY; Tohnai I
    Head Neck; 2013 Mar; 35(3):E89-93. PubMed ID: 21953943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer.
    Mitsudo K; Shigetomi T; Fujimoto Y; Nishiguchi H; Yamamoto N; Furue H; Ueda M; Itoh Y; Fuwa N; Tohnai I
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1428-35. PubMed ID: 20605340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of weekly cisplatin chemoradiotherapy for patients with pyriform sinus cancer.
    Sakashita T; Homma A; Hatakeyama H; Furusawa J; Kano S; Mizumachi T; Iizuka S; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
    Int J Clin Oncol; 2015 Dec; 20(6):1081-5. PubMed ID: 25804347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of advanced maxillary sinus squamous carcinoma: an analysis of 92 cases].
    Su YR; Wu GH; Zeng ZY; Guo ZM; Chen WK; Wei MW; Chen YF
    Ai Zheng; 2008 May; 27(5):535-8. PubMed ID: 18479606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new aspect of tri-modal therapy with superselective intra-arterial chemotherapy in maxillary sinus carcinoma.
    Fujishiro Y; Nakao K; Watanabe K; Ebihara Y; Nakamura N; Mori H; Hayashi N; Asakage T
    Acta Otolaryngol Suppl; 2007 Dec; (559):151-6. PubMed ID: 18340587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes between concurrent chemoradiotherapy and combination of surgery, radiotherapy, and/or chemotherapy in stage III and IV maxillary sinus cancer: multi-institutional retrospective analysis.
    Kang JH; Cho SH; Kim JP; Kang KM; Cho KS; Kim W; Seol YM; Lee S; Park HS; Hur WJ; Choi YJ; Oh SY
    J Oral Maxillofac Surg; 2012 Jul; 70(7):1717-23. PubMed ID: 21945430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage surgery for residual primary and locally recurrent anal squamous cell carcinoma after chemoradiotherapy in HIV-positive individuals.
    Cunin L; Alfa-Wali M; Turner J; Bower M; Ion L; Allen-Mersh T
    Ann Surg Oncol; 2014 Feb; 21(2):527-32. PubMed ID: 24242676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.
    Kato K; Nakajima TE; Ito Y; Katada C; Ishiyama H; Tokunaga SY; Tanaka M; Hironaka S; Hashimoto T; Ura T; Kodaira T; Yoshimura K
    Jpn J Clin Oncol; 2013 Jun; 43(6):608-15. PubMed ID: 23585687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermochemoradiation therapy using superselective intra-arterial infusion via superficial temporal and occipital arteries for oral cancer with N3 cervical lymph node metastases.
    Mitsudo K; Koizumi T; Iida M; Iwai T; Oguri S; Yamamoto N; Itoh Y; Kioi M; Hirota M; Tohnai I
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e639-45. PubMed ID: 22543212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents.
    Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
    Acta Otolaryngol; 2013 Mar; 133(3):318-26. PubMed ID: 23153059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superselective intra-arterial chemotherapy with concurrent radiotherapy for advanced parotid squamous cell carcinoma: a case report.
    Kashiwagi N; Fujii T; Nishiyama K; Nakanishi K; Tomiyama N; Yagyu Y; Tsurusaki M; Kitano M; Murakami T
    Jpn J Clin Oncol; 2015 Apr; 45(4):378-80. PubMed ID: 25657260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of superselective intra-arterial infusion with concomitant radiotherapy for adenoid cystic carcinoma of the head and neck.
    Homma A; Sakashita T; Hatakeyama H; Kano S; Mizumachi T; Nakamaru Y; Yoshida D; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
    Acta Otolaryngol; 2015 Sep; 135(9):950-4. PubMed ID: 25925195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer.
    Homma A; Sakashita T; Yoshida D; Onimaru R; Tsuchiya K; Suzuki F; Yasuda K; Hatakeyama H; Furusawa J; Mizumachi T; Kano S; Inamura N; Taki S; Shirato H; Fukuda S
    Br J Cancer; 2013 Dec; 109(12):2980-6. PubMed ID: 24196792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal.
    Eng C; Chang GJ; You YN; Das P; Xing Y; Delclos M; Wolff RA; Rodriguez-Bigas MA; Skibber J; Ohinata A; Gould S; Phillips J; Crane CH
    Cancer; 2013 Nov; 119(21):3769-75. PubMed ID: 24037775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.
    Koo DH; Park SI; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Yoon DH; Kim SB
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):655-63. PubMed ID: 21968953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.